EMA — authorised 25 April 2022
- Marketing authorisation holder: Horizon Therapeutics Ireland DAC
- Status: approved
🇪🇺 Uplizna in European Union
EMA authorised Uplizna on 25 April 2022
Marketing authorisation
Uplizna in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Neuroscience approved in European Union
Frequently asked questions
Is Uplizna approved in European Union?
Yes. EMA authorised it on 25 April 2022.
Who is the marketing authorisation holder for Uplizna in European Union?
Horizon Therapeutics Ireland DAC holds the EU marketing authorisation.